Position in ZTS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,365,736
New position
Shares Held
20,013
first reported quarter
Ownership
0.005%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 53.23539699195523.ToString("F0")%
None 46.76460300804477.ToString("F0")%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026LEVIN CAPITAL STRATEGIES, L.P. holds $16,411,177 across 2 Drug Manufacturers - Specialty & Generic names. ZTS ranks #2 (14.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
1,039,633 | $14,045,441 | |
| 2 | ZTS |
Zoetis Inc.
This page
|
20,013 | $2,365,736 |
All Filings in ZTS
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,365,736 | 20,013 | Shares | Other | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||